Açiq mənbələrdən foto.
Baku/03.05.21/Turan: The State Agency for Compulsory Health Insurance (SACHI) has finally answered the questions of the Turan agency's information request regarding the advisability of using the Astrazeneca vaccine in connection with negative responses to this vaccine in Western countries.
“Although the conflict is formally settled, and we received answers to the questions, they have lost their relevance today. However, public interest was not satisfied when the topic of AstraZeneka was on the agenda,” said director of the agency Mehman Aliyev. The representative of the State Agency called Turan and explained that the untimely response was caused by technical reasons and the department want to maintain working relations with the press.
"For some reason, there was a delay in the development of the website of the Association for the Management of Territorial Medical Units (TƏBIB), but the issue is being resolved," said the representative of the State Agency for Medical Insurance. Because the required information has been provided, Turan will not appeal to the court due to failure to provide an answer to the information request. This is the content of the responses to the agency's request:
Question 1) Who signed the agreement to purchase the Aztrazeneca vaccine?
Answer: The import of the AztraZeneca vaccine into the country is carried out through the COVAX platform to vaccinate the population in order to prevent the coronavirus pandemic. Azerbaijan joined the COVAX platform in September last year.
Question 2) What is the price and quantity of the vaccine purchased under this agreement?
Answer: The agreement provides for the delivery of 432,000 doses of the Aztrazeneca COVID-19 vaccine to Azerbaijan. On April 4, 84,000 doses of COVID-19 vaccine were delivered from Korea to the country.
In addition, the COVAX platform provides for the delivery of 218,790 doses of Pfizer-BioNTech vaccine to the country.
Question 3) Will the agreement be terminated because of the reports on the suspension of the use of the AztraZeneca vaccine by a number of countries or not?
Answer: In a statement on April 8, the World Health Organization noted that the benefits of the AztraZeneca vaccine are higher than its risks and the WHO recommends its use. -0-
Social
-
"The biggest challenge in the education sector is the low number of fully staffed schools," said Minister of Science and Education Emin Amrullayev on November 20 during a joint session of the Parliamentary Committees on Agrarian Policy, Family, Women, and Children Issues, and Science and Education. The session was held to discuss the draft law on the "State Budget for 2025," according to local media reports.
-
The innovation and speed leader Bakcell organized a panel discussion on the topic “Sustainability Through Artificial Intelligence.” The event featured speakers including Bakcell’s Marketing Director Elkhan Sadiqzade, PwC Azerbaijan’s Head of Advisory Services Farid Qattal, and the Head of Innovation at the Innovation and Digital Development Agency Evgeniya Bikmurzina. The panel was moderated by Aysel Suleymanova, Bakcell’s Director of Corporate Communications and Public Relations.
-
On Saturday, the weather in Baku will be variable, with possible drizzle by the evening. There will be fog in some areas in the morning and evening. A moderate northwest wind will change to the southeast by evening. The temperature at night will range from +9 to +12°C, and during the day it will be between +13 and +18°C. Humidity will be 75–85%.
-
A Lufthansa airliner flying from Mumbai to Munich made an emergency landing at Heydar Aliyev International Airport early Wednesday after a passenger suffered a sudden medical emergency, airport officials said.
Leave a review